增强瘤向治疗:iRGD在先进药物输送系统中的作用
Dragana Nikitovic1, Ekaterina Kukovyakina2, Aikaterini Berdiaki1
1Department of Histology-Embryology, Medical School, University of Crete, 71003 Heraklion, Greece.
Cancers
|November 27, 2024
概括
该iRGD通过改善药物透到固体瘤来增强化疗. 这种细胞透可以向瘤细胞,增加药物输送和治疗疗效,同时最大限度地减少副作用.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 纳米技术 纳米技术
背景情况:
- 化疗是一种主要的癌症治疗方法,但药物输送到固体瘤往往是由于透率差而受到限制.
- 瘤微环境 (TME) 对有效的药物输送构成重大障碍.
- 细胞透 (CPPs) 提供了一种增强治疗剂内化策略.
研究的目的:
- 审查iRGD在克服癌症中药物输送障碍方面的作用机制.
- 探索基于iRGD的药物输送系统及其应用.
- 讨论iRGD结合疗法的未来前景.
主要方法:
- 对iRGD,CPP和瘤微环境的现有文献的审查.
- 对iRGD双受体向机制 (整体蛋白αvβ3/αvβ5和神经皮林受体) 的分析.
- 检查iRGD在增强血管透性和药物透中的作用.
主要成果:
- 该iRGD通过向瘤细胞上的特定受体,有效地穿透瘤组织.
- iRGD增强了瘤血管的通透性,促进了更深的药物和纳米粒子输送.
- 这种双重作用提高了联合使用的癌症疗法的疗效.
结论:
- 在固体瘤中,iRGD体显示出克服药物输送挑战的巨大潜力.
- 基于iRGD的策略可以提高治疗效率并减少副作用.
- 为了改善癌症治疗,需要进一步开发iRGD结合疗法.
更多相关视频
10:36In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
7.6K
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.2K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Carrier-Mediated Transport
278
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
278
